Arena Pharmaceuticals to Present Additional PreClinical Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at International Congress of the European Respiratory Society

SAN DIEGO Sept. 6 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA will present additional detailed preclinical pharmacology and pharmacokinetic data on ralinepag APD811 the Company's nextgeneration oral selective prostacyclin receptor IP agonist in...